Detalhe da pesquisa
1.
Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters.
J Virol
; 97(1): e0136622, 2023 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36633406
2.
High-throughput isolation of SARS-CoV-2 nucleocapsid antibodies for improved antigen detection.
Biochem Biophys Res Commun
; 673: 114-120, 2023 09 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37379800
3.
Mpox Neutralizing Antibody Response to LC16m8 Vaccine in Healthy Adults.
NEJM Evid
; 3(3): EVIDoa2300290, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38411447
4.
Results from a preclinical study in rodents and a Phase 1/2, randomized, double-blind, placebo-controlled, parallel-group study of COVID-19 vaccine S-268019-a in Japanese adults.
Vaccine
; 41(11): 1834-1847, 2023 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36572603
5.
Saturation time of exposure interval for cross-neutralization response to SARS-CoV-2: Implications for vaccine dose interval.
iScience
; 26(5): 106694, 2023 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37124417
6.
Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways.
Nat Commun
; 13(1): 6100, 2022 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36243815
7.
Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology.
Vaccine
; 40(41): 5892-5903, 2022 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36064667
8.
Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys.
Vaccine
; 40(31): 4231-4241, 2022 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35691872
9.
Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including the Omicron variants.
Antiviral Res
; 201: 105297, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35341809
10.
Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice.
Sci Rep
; 12(1): 20861, 2022 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36460696
11.
Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants.
Med
; 3(4): 249-261.e4, 2022 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35261995
12.
Author Correction: Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice.
Sci Rep
; 14(1): 2599, 2024 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38297027